1) Japanese CSG, Matsusaki K, Ohta K, et al:Novel cell-free and concentrated ascites reinfusion therapy(KM-CART)for refractory ascites associated with cancerous peritonitis:its effect and future perspectives. Int J Clin Oncol 2011;16:395-400 2) Orimi S, Mizuno K, Narahara M, et al:A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites. Ther Apher Dial 2011;15:411-4 3) Maeda A, Takeda K, Tsuruya K, et al:A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient. Case Rep Nephrol Urol 2012;2:138-44 4) Ueda T, Maehara M, Takahashi Y, et al:Clinical significance of cell-free and concentrated ascites re-infusion therapy for advanced and recurrent gynecological cancer. Anticancer Res 2012;32:2353-7 5) Takahashi H, Sakai R, Fujita A, et al:Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation. Artif Organs 2013;37:932-6 6) Ito T, Hanafusa N, Fukui M, et al:Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites. Ther Apher Dial 2014;18:87-92 7) Maeda O, Ando T, Ishiguro K, et al:Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer. Mol Clin Oncol 2014;2:1103-6 8) Togami S, Hori S, Kamio M, et al:Clinical usefulness of concentrated ascites reinfusion therapy(CART)for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis. Eur J Gynaecol Oncol 2014;35:301-3 9) Ito T, Hanafusa N, Iwase S, et al:Effects of cell-free and concentrated ascites reinfusion therapy(CART)on symptom relief of malignancy-related ascites. Int J Clin Oncol 2015;20:623-8 10) Maeda S, Yabuuchi J, Nobuta H, et al:Characteristics of patients and their ascites who underwent repeated cell-free and concentrated ascites reinfusion therapy. Ther Apher Dial 2015;19:342-8 11) Wang L, Okubo T, Shinsaka M, et al:Efficacy and safety of cell-free and concentrated ascites reinfusion therapy(CART)in gynecologic cancer patients with a large volume of ascites. J Obstet Gynaecol Res 2015;41:1614-20 12) Yamaguchi H, Kitayama J, Emoto S, et al:Cell-free and concentrated ascites reinfusion therapy(CART)for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1. Eur J Surg Oncol 2015;41:875-80 13) Kozaki K, Iinuma M, Takagi T, et al:Cell-free and concentrated ascites reinfusion therapy for decompensated liver Cirrhosis. Ther Apher Dial 2016;20:376-82 14) Matsusaki K:A new treatment strategy-novel cell-free and concentrated ascites reinfusion system(KM-CART)for massive malignant ascites. Gan To Kagaku Ryoho 2016;43:2490-7 15) Hanafusa N, Isoai A, Ishihara T, et al:Safety and efficacy of cell-free and concentrated ascites reinfusion therapy(CART)in refractory ascites:Post-marketing surveillance results. PLoS One 2017;12:e0177303 16) Hisakane K, Ohmatsu H, Umemura S, et al:Efficacy of cell-free and concentrated ascites reinfusion therapy for palliative care in a patient with malignant pleural mesothelioma:A case report. J Nippon Med Sch 2017;84:231-6 17) Ito T, Hanafusa N:CART:Cell-free and concentrated ascites reinfusion therapy against malignancy-related ascites. Transfus Apher Sci 2017;56:703-7 18) Ogasawara M, Miyashita M, Iida M, et al:Immunological analysis and generation of dendritic cells from lavage fluid obtained by cell-free and concentrated ascites reinfusion therapy. Ther Apher Dial 2017;21:255-62 19) Yamada Y, Yamaguchi A, Harada M, et al:Protein concentration of refractory ascites in cancer patients is reflected by the presence and severity of peritoneal and liver metastasis. Ther Apher Dial 2017;21:263-9 20) Hanada R, Yokomichi N, Kato C, et al:Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites:a concept-proof study. Support Care Cancer 2018;26:1489-97